Medicare Enrolled

Dr. Colin McLeod, M.D.

Neurology · Augusta, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Research-focused
1120 15TH ST, Augusta, GA 30912
7067218623
In practice since 2013 (13 years)
NPI: 1750720124 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. McLeod from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McLeod? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. McLeod

Dr. Colin McLeod is a neurology specialist in Augusta, GA, with 13 years of NPI registration. Based on federal Medicare data, Dr. McLeod performed 751 Medicare services across 388 unique beneficiaries.

Between the years covered by Open Payments, Dr. McLeod received a total of $44,607 from 54 pharmaceutical and/or device companies across 537 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are classified as research and scientific activities (grants and research funding). Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. McLeod is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ Top 34% volume in GA $44,607 industry payments

Medicare Practice Summary

Medicare Utilization ↗
751
Medicare services
Top 34% in GA for neurology
388
Unique beneficiaries
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~58 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
149 $101 $245
Brain stimulator programming, additional 15 minutes
Electronic analysis and programming of an implanted brain neurostimulator generator by a qualified health professional. This code applies to each additional 15-minute increment beyond the initial service.
123 $34 $110
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle 121 $14 $76
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
70 $68 $172
Brain stimulator programming, first 15 minutes
Electronic analysis of an implanted brain, spinal cord, or peripheral neurostimulator generator. This service includes programming the brain stimulator by a qualified health professional for the first 15 minutes.
65 $38 $126
Chemical nerve block for neck muscles
Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box.
64 $114 $229
Chemical nerve block for facial paralysis
Injection of a chemical agent to paralyze specific nerves or muscles on the side of the face.
40 $96 $467
New patient office visit, complex (60-74 min) 36 $129 $368
Chemical nerve block injection, 1-4 muscles
An injection of a chemical agent to paralyze specific muscles in an arm or leg. This procedure targets one to four muscles in the first extremity treated.
35 $72 $209
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
18 $48 $111
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
16 $97 $283
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
14 $62 $162
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$44,607
Total received (2018-2024)
Avg $6,372/year across 7 years
Top 9% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
537
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Scientific / Research
Research funding and grants
$26,236 (58.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,028 (27.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,374 (7.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,969 (6.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,317
2023
$2,315
2022
$5,558
2021
$6,122
2020
$874
2019
$6,929
2018
$20,491

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$542
MDD US Operations, LLC
$466
Neurocrine Biosciences, Inc.
$331
Alexion Pharmaceuticals, Inc.
$119
Teva Pharmaceuticals USA, Inc.
$114
Merz Pharmaceuticals, LLC
$73
Eisai Inc.
$66
Lilly USA, LLC
$66
Takeda Pharmaceuticals U.S.A., Inc.
$61
ARGENX US, INC.
$60
Ipsen Biopharmaceuticals, Inc
$58
Kyowa Kirin, Inc.
$51
Amneal Pharmaceuticals LLC
$50
Acorda Therapeutics, Inc
$46
Otsuka America Pharmaceutical, Inc.
$46
ACADIA Pharmaceuticals Inc
$38
Lundbeck LLC
$32
SK Life Science, Inc.
$24
AstraZeneca Pharmaceuticals LP
$24
Kedrion Biopharma, Inc.
$21
Neurelis, Inc.
$15
Boston Scientific Corporation
$14
Top 3 companies account for 57.8% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic USA, Inc.
$26,236
Amneal Pharmaceuticals LLC
$3,141
Medtronic, Inc.
$2,309
AbbVie Inc.
$1,804
Avion Pharmaceuticals
$1,726
ABBVIE INC.
$1,365
MDD US Operations, LLC
$889
Teva Pharmaceuticals USA, Inc.
$829
Neurocrine Biosciences, Inc.
$764
Abbott Laboratories
$536
ACADIA Pharmaceuticals Inc
$525
Acorda Therapeutics, Inc
$373
Kyowa Kirin, Inc.
$321
Alexion Pharmaceuticals, Inc.
$307
Sunovion Pharmaceuticals Inc.
$239
Adamas Pharmaceuticals, Inc.
$238
MITSUBISHI TANABE PHARMA AMERICA, INC.
$231
Ipsen Biopharmaceuticals, Inc
$215
Eisai Inc.
$206
Merz Pharmaceuticals, LLC
$183
Avanir Pharmaceuticals, Inc.
$165
Allergan, Inc.
$153
ARGENX US, INC.
$139
Lundbeck LLC
$128
BOSTON SCIENTIFIC CORPORATION
$127
AbbVie, Inc.
$115
US WorldMeds, LLC
$113
Biogen, Inc.
$106
Amgen Inc.
$98
Otsuka America Pharmaceutical, Inc.
$94
Biohaven Pharmaceutical Holding Company Ltd.
$84
SK Life Science, Inc.
$81
Lilly USA, LLC
$66
PFIZER INC.
$66
Saol Therapeutics Inc.
$61
Takeda Pharmaceuticals U.S.A., Inc.
$61
JAZZ PHARMACEUTICALS INC.
$58
EISAI INC.
$58
Boston Scientific Corporation
$55
Allergan Inc.
$44
Vertical Pharmaceuticals, LLC
$38
Neurelis, Inc.
$32
Genentech USA, Inc.
$27
Baxter Healthcare
$24
AstraZeneca Pharmaceuticals LP
$24
Greenwich Biosciences, Inc.
$23
Kedrion Biopharma, Inc.
$21
Supernus Pharmaceuticals, Inc.
$18
Novartis Pharmaceuticals Corporation
$17
E.R. Squibb & Sons, L.L.C.
$17
Alnylam Pharmaceuticals Inc.
$16
Mitsubishi Tanabe Pharma America, Inc.
$15
Merz North America, Inc.
$14
NATUS MEDICAL INCORPORATED
$11
Top 3 companies account for 71.0% of all-time payments
Associated products mentioned in payments ›
ACTIVA · ADUHELM · AJOVY · AMYVID · APOKYN · AUSTEDO · Aimovig · Albuked · Austedo XR · BOTOX · CREXONT · DIVIGEL · DUOPA · DYSPORT · Dhivy · Duopa · Dysport · ELIQUIS · EPIDIOLEX · Epidiolex · Evrysdi · FLOSEAL · Fycompa · GENERAL DBS · GENERAL - DBS · GILENYA · GOCOVRI · Gocovri · HYQVIA · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KYNMOBI · LATUDA · Leqembi · Lioresal (baclofen) · MYOBLOC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · ONGENTYS · ONPATTRO · OSMOLEX ER · Ongentys · PERCEPT PC BRAINSENSE · QULIPTA · RADICAVA · REXULTI · RYTARY · SOLIRIS · SPINRAZA · SenSight · Skyclarys · TROKENDI XR · UBRELVY · ULTOMIRIS · VALTOCO · VERCISE · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · WAINUA · XEOMIN · Xadago · Xeomin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (59%) are classified as scientific/research, suggesting involvement in clinical studies, grants, or innovation-related work. Total industry engagement is in the top 9% for neurology in GA.

Looking for a neurology specialist in Augusta?
Compare neurologists in the Augusta area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
83
Per 100K population
40.3
County median income
$53,197
Nearest hospital
WELLSTAR MCG HEALTH, AFFILIATED WITH MED COL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. McLeod is a clinical cardiology specialist, with moderate Medicare volume, with research-focused industry engagement in the top 9% of GA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. McLeod experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. McLeod performed 149 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McLeod receive payments from pharmaceutical companies?
Yes. Dr. McLeod received a total of $44,607 from 54 companies across 537 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McLeod's costs compare to other neurologists in Augusta?
Dr. McLeod's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McLeod) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →